Skip to main content
. 2017 Aug 30;7:9982. doi: 10.1038/s41598-017-10155-x

Table 2.

Antibiotic susceptibility profiles of C. difficile 630Δerm control versus cd2068 mutant and the cd2068 mutants carrying pMTL84151 and pMTL-cd2068.

Antibiotics IC50(μg/ml) Relative sensitivity IC50 (μg/ml) Relative resistance
Control cd2068 mutant cd2068 mutant + pMTL84151 cd2068 mutant + pMTL-cd2068
Ampicillin 29.84 ± 3.2 17.13 ± 0.7 1.7* 14.24 ± 0.6 25.56 ± 1.2 1.8*
Cefoxitin 33.69 ± 1.3 20.54 ± 2.7 1.6* 20.72 ± 1.1 46.03 ± 6.8 2.2*
Ciprofloxacin 12.26 ± 0.5 7.81 ± 0.2 1.6* 20.94 ± 0.6 34.50 ± 0.7 1.7*
Cloxacillin 16.90 ± 0.6 4.76 ± 0.3 3.6* 7.92 ± 0.3 9.73 ± 0.5 1.2*
Gentamicin 28.60 ± 2.3 22.72 ± 2.7 1.3* 107.83 ± 9.1 103.62 ± 15.3 1.0
Levofloxacin 7.28 ± 0.4 5.81 ± 0.7 1.3* 6.89 ± 0.8 10.03 ± 0.1 1.5*
Metronidazole 3.33 ± 0.5 2.37 ± 0.1 1.4* 2.36 ± 0.1 3.23 ± 0.1 1.4*
Vancomycin 2.01 ± 0.3 1.82 ± 0.2 1.1 3.38 ± 0.1 2.11 ± 0.1 0.6

Relative sensitivity refers to the fold difference in the IC50 values of the cd2068 mutant compared to the control cells. Relative resistance refers to the fold difference in the IC50 values of the cd2068 mutant carrying pMTL84151 compared to the cd2068 mutant carrying pMTL-cd2068. Asterisks represent the p value of less than 0.05.